GENOMIC VALLEY BIOTECH LIMITED (GVBL.BO)
INR 79.0
(-2.71%)
INR 79.0
(-2.71%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.65 Million INR | -85.48% |
| 2022 | 11.36 Million INR | 1568.68% |
| 2021 | 681.15 Thousand INR | -12.57% |
| 2020 | 779.04 Thousand INR | -90.63% |
| 2019 | 8.31 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 1.55 Million INR | 0.0% |
| 2023 Q3 | 390 Thousand INR | -42.24% |
| 2023 Q1 | 585.5 Thousand INR | -94.11% |
| 2023 Q4 | - INR | -100.0% |
| 2023 FY | 1.65 Million INR | -85.48% |
| 2023 Q2 | 675.25 Thousand INR | 15.33% |
| 2022 Q2 | 205 Thousand INR | 0.0% |
| 2022 FY | 11.36 Million INR | 1568.68% |
| 2022 Q3 | 702.24 Thousand INR | 242.56% |
| 2022 Q4 | 9.93 Million INR | 1315.27% |
| 2021 FY | 681.15 Thousand INR | -12.57% |
| 2020 FY | 779.04 Thousand INR | -90.63% |
| 2019 FY | 8.31 Million INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 10.46 Million INR | 84.22% |
| Biocon Limited | 91.73 Billion INR | 99.998% |
| Blue Jet Healthcare Limited | 3.15 Billion INR | 99.948% |
| Concord Biotech Limited | 6.11 Billion INR | 99.973% |
| Dishman Carbogen Amcis Limited | 4.9 Billion INR | 99.966% |
| FERMENTA BIOTECH LIMITED | 1.82 Billion INR | 99.909% |
| Lyka Labs Limited | 145.95 Million INR | 98.869% |
| Panacea Biotec Limited | 1.35 Billion INR | 99.878% |
| SAMSRITA LABS LIMITED | -1.28 Million INR | 228.656% |
| Servoteach Industries Limited | - INR | -Infinity% |
| SMS Lifesciences India Limited | 329.57 Million INR | 99.499% |
| Supriya Lifescience Limited | 2.65 Billion INR | 99.938% |
| Syngene International Limited | 12.43 Billion INR | 99.987% |
| TAKE Solutions Limited | 183.42 Million INR | 99.1% |
| Titan Biotech Limited | 884.66 Million INR | 99.813% |
| Transgene Biotek Limited | -1.69 Million INR | 197.562% |
| Vanta Bioscience Limited | 7.12 Million INR | 76.815% |